Agile Therapeutics' Q3 Focused on Launching Its New Contraceptive Patch
Investors can't complain about Agile Therapeutics' (NASDAQ: AGRX) stock performance so far this year. The drugmaker's shares are up nearly 17% year to date after a strong rebound from the market meltdown in the first quarter of 2020.
Agile announced its third-quarter results after the market closed on Thursday. Here are the highlights from the company's Q3 update.
Image source: Getty Images.
Source Fool.com
